Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Jia, Deshui ^a   Yan, Mingxia ^a   Wang, Xiaomin ^a   Hao, Xiangfang ^a   Liang, Linhui ^a   Liu, Lei ^a   Kong, Hanwei ^a   He, Xianghuo ^a   Li, Jinjun ^a   Yao, Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; SHORT HAIRPIN RNA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL MODEL; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; VALIDATION PROCESS; ADENOCARCINOMA; ANIMAL; APOPTOSIS; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CLONOGENIC ASSAY; DISEASE MODEL; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 77954330516     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-364     Document Type: Article

References (41)

1. Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Lozano G, et al. Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS ONE 2009, 4(4):e5401. 10.1371/journal.pone.0005401, 2671160, 19404390.
2. Tanaka E, Yamashita J, Hayashi N, Kato S, Kondo K, Ogawa M. A pulmonary metastatic model of human non-small cell lung carcinoma cells that produce a neutrophil elastase-like molecule in severe combined immunodeficiency mice. Chest 2003, 123(4):1248-1253. 10.1378/chest.123.4.1248, 12684318.
3. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406(6795):532-535. 10.1038/35020106, 10952316.
4. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436(7050):518-524. 10.1038/nature03799, 1283098, 16049480.
5. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39(3):305-318. 10.1080/00313020701329914, 17558857.
6. Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 2009, 22(5):668-678. 10.1038/modpathol.2009.19, 2675657, 19270647.
7. Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cellular signalling 2009, 21(5):704-711. 10.1016/j.cellsig.2009.01.008, 19166932.
8. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nature reviews 2009, 9(4):239-252. 10.1038/nrc2618, 19279573.
9. Hu M, Carles-Kinch KL, Zelinski DP, Kinch MS. EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. Mol Cancer Res 2004, 2(10):533-540.
10. Zheng Y, Ritzenthaler JD, Roman J, Han S. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. American journal of respiratory cell and molecular biology 2007, 37(6):681-690. 10.1165/rcmb.2007-0051OC, 17600315.
11. Ritzenthaler JD, Han S, Roman J. Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Molecular bioSystems 2008, 4(12):1160-1169. 10.1039/b800533h, 19396378.
12. Han S, Khuri FR, Roman J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer research 2006, 66(1):315-323. 10.1158/0008-5472.CAN-05-2367, 16397245.
13. Han S, Ritzenthaler JD, Sitaraman SV, Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. The Journal of biological chemistry 2006, 281(40):29614-29624. 10.1074/jbc.M604013200, 16882662.
14. Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY, et al. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. British journal of cancer 2009, 101(2):327-334. 10.1038/sj.bjc.6605154, 19568240.
15. Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Journal of cancer research and clinical oncology 2003, 129(1):43-51. 10.1007/s00432-003-0493-z, 12618900.
16. Wu D, Chen X, Guo D, Hong Q, Fu B, Ding R, Yu L, Hou K, Feng Z, Zhang X, et al. Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. J Am Soc Nephrol 2005, 16(3):646-657. 10.1681/ASN.2004060445, 15677310.
17. Caceres G, Zhu XY, Jiao JA, Zankina R, Aller A, Andreotti P. Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence 2003, 18(4):218-223. 10.1002/bio.729, 12950058.
18. Ciana P, Brena A, Sparaciari P, Bonetti E, Di Lorenzo D, Maggi A. Estrogenic activities in rodent estrogen-free diets. Endocrinology 2005, 146(12):5144-5150. 10.1210/en.2005-0660, 16150910.
19. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumourigenicity. International journal of cancer 2007, 120(7):1444-1450.
20. Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clinical & experimental metastasis 2008, 25(5):517-529.
21. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP. CD24 expression causes the acquisition of multiple cellular properties associated with tumour growth and metastasis. Cancer research 2005, 65:10783-10793. 10.1158/0008-5472.CAN-05-0619, 16322224.
22. Munoz R, Man S, Shaked Y, Lee CR, Wong J, Francia G, Kerbel RS. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer research 2006, 66(7):3386-3391. 10.1158/0008-5472.CAN-05-4411, 16585158.
23. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumour metastasis. Developmental cell 2008, 14(6):818-829. 10.1016/j.devcel.2008.05.009, 18539112.
24. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7(2):131-142. 10.1038/nrm1835, 16493418.
25. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 2004, 117(7):927-939. 10.1016/j.cell.2004.06.006, 15210113.
26. Fidler IJ. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer metastasis reviews 1991, 10(3):229-243. 10.1007/BF00050794, 1764766.
27. Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumour model. Lung cancer (Amsterdam, Netherlands) 2008, 60(3):347-354.
28. Fork MA, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HJ, Bullerdiek J, et al. Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC cancer 2008, 8:240. 10.1186/1471-2407-8-240, 2527616, 18706092.
29. Cruz-Munoz W, Man S, Xu P, Kerbel RS. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer research 2008, 68(12):4500-4505. 10.1158/0008-5472.CAN-08-0041, 18559492.
30. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumours. Nature genetics 2003, 33(1):49-54. 10.1038/ng1060, 12469122.
31. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 2003, 5(1):57-58. 10.1186/bcr562, 154139, 12559048.
32. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer cell 2003, 3(6):537-549. 10.1016/S1535-6108(03)00132-6, 12842083.
33. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, et al. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. The EMBO journal 2002, 21(8):1948-1956. 10.1093/emboj/21.8.1948, 125968, 11953314.
34. Najy AJ, Day KC, Day ML. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. The Journal of biological chemistry 2008, 283(26):18393-18401. 10.1074/jbc.M801329200, 2440598, 18434311.
35. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Journal of cell science 2001, 114(Pt 1):111-118.
36. Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer research 2006, 66(23):11271-11278. 10.1158/0008-5472.CAN-06-2044, 17145872.
37. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & experimental metastasis 2008, 25(6):621-628.
38. Christofori G. New signals from the invasive front. Nature 2006, 441(7092):444-450. 10.1038/nature04872, 16724056.
39. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature reviews 2002, 2(8):563-572. 10.1038/nrc865, 12154349.
40. Berrier AL, Yamada KM. Cell-matrix adhesion. Journal of cellular physiology 2007, 213(3):565-573. 10.1002/jcp.21237, 17680633.
41. Pankov R, Yamada KM. Fibronectin at a glance. Journal of cell science 2002, 115(Pt 20):3861-3863. 10.1242/jcs.00059, 12244123.